182 related articles for article (PubMed ID: 10834181)
41. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis.
Perret-Guillaume C; Wahl DG
Thromb Haemost; 2004 Feb; 91(2):394-402. PubMed ID: 14961170
[TBL] [Abstract][Full Text] [Related]
42. [Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment].
Steinbeck G
MMW Fortschr Med; 2006 Apr; 148(15):31. PubMed ID: 16711198
[No Abstract] [Full Text] [Related]
43. [Long term prevention of thromboembolic accidents with acetylsalicylic acid in auricular fibrillation patients].
Buen Abad LH; Elizalde Galván JA; Cárdenas M
Arch Inst Cardiol Mex; 1976; 46(6):764-9. PubMed ID: 1023834
[TBL] [Abstract][Full Text] [Related]
44. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Dunkman WB; Johnson GR; Carson PE; Bhat G; Farrell L; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI94-101. PubMed ID: 8500246
[TBL] [Abstract][Full Text] [Related]
45. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS
Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308
[TBL] [Abstract][Full Text] [Related]
46. [Diagnosis and treatment of cerebrovascular accidents of cardioembolic origin].
Ricou FJ; Arroyo JF
Praxis (Bern 1994); 1996 Feb; 85(6):155-8. PubMed ID: 8701177
[TBL] [Abstract][Full Text] [Related]
47. [Occurrence of thromboembolic complications in patients with dilated cardiomyopathy. Retrospective-prospective study].
Polić S; Biocić M; Lukin A; Rumboldt Z; Bagatin J; Pivac N; Rakić D; Naranca M
Lijec Vjesn; 1997; 119(5-6):142-6. PubMed ID: 9379820
[TBL] [Abstract][Full Text] [Related]
48. [Platelet antiaggregants in cerebral ischemic pathology].
Adams D; Bousser MG
Rev Prat; 1989 Nov; 39(25):2234-40. PubMed ID: 2688044
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation.
Inoue H; Atarashi H;
Am J Cardiol; 2000 Oct; 86(8):852-5. PubMed ID: 11024400
[TBL] [Abstract][Full Text] [Related]
50. Anticoagulant treatment of atrial fibrillation in the elderly.
Dunn M; Blackburn T
Postgrad Med J; 1992; 68 Suppl 1():S57-60. PubMed ID: 1409218
[TBL] [Abstract][Full Text] [Related]
51. Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results.
Schmid C; Weyand M; Hammel D; Deng MC; Nabavi D; Scheld HH
Thorac Cardiovasc Surg; 1998 Oct; 46(5):260-2. PubMed ID: 9885115
[TBL] [Abstract][Full Text] [Related]
52. [Prevention of thromboembolism in patients with atrial fibrillation].
Schmidt M; Brömsen J; Blumenstein M
MMW Fortschr Med; 2006 Apr; 148(15):36-7, 39-40. PubMed ID: 16711200
[TBL] [Abstract][Full Text] [Related]
53. Stroke prevention in atrial fibrillation--things can only get better.
Lip GY; Watson T
Br J Clin Pharmacol; 2007 Nov; 64(5):575-7. PubMed ID: 17578482
[No Abstract] [Full Text] [Related]
54. The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation.
Colkesen Y; Coskun I; Muderrisoglu H
Platelets; 2013; 24(4):263-6. PubMed ID: 22647033
[TBL] [Abstract][Full Text] [Related]
55. [The AVERROES study].
De Caterina R; Abbate R
G Ital Cardiol (Rome); 2011 Sep; 12(9):551-5. PubMed ID: 21892215
[No Abstract] [Full Text] [Related]
56. Atrial fibrillation treatment update.
Clem JR
S D Med; 2011 Jul; 64(7):255-6. PubMed ID: 21848023
[No Abstract] [Full Text] [Related]
57. [Antiaggregants in the prevention of ischemic cardiopathy and systemic thromboembolism].
Pérez Gómez F; Pérez Vizcaíno F
Rev Port Cardiol; 1995; 14(7-8):525-31. PubMed ID: 7669326
[TBL] [Abstract][Full Text] [Related]
58. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
Hellemons BS; Langenberg M; Lodder J; Vermeer F; Schouten HJ; Lemmens T; van Ree JW; Knottnerus JA
BMJ; 1999 Oct; 319(7215):958-64. PubMed ID: 10514159
[TBL] [Abstract][Full Text] [Related]
59. Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Rutten FH; Hak E; Stalman WA; Verheij TJ; Hoes AW
Fam Pract; 2003 Feb; 20(1):16-21. PubMed ID: 12509365
[TBL] [Abstract][Full Text] [Related]
60. [Indications of vitamin K antagonists and aspirin in the atrial fibrillation of the elderly].
Gentric A; Estivin S; Jestin C
Rev Med Interne; 2009 Aug; 30(8):671-7. PubMed ID: 19095331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
